Article
Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.
TheScientificWorldJournal - 1 Jan 2013
Catarzi Serena, Caciotti Anna, Thusberg Janita, Tonin Rodolfo, Malvagia Sabrina, la Marca Giancarlo, Pasquini Elisabetta, Cavicchi Catia, Ferri Lorenzo, Donati Maria A, Baronio Federico, Guerrini Renzo, Mooney Sean D, Morrone Amelia
Abstract excerpt
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is a disorder of fatty acid oxidation characterized by hypoglycemic crisis under fasting or during stress conditions, leading to lethargy, seizures, brain damage, or even death. Biochemical acylcarnitines data obtained through newborn screening by liquid chromatography-tandem mass spectrometry (LC-MS/MS) were confirmed by molecular analysis of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
